|
Volumn 19, Issue 2, 2016, Pages 154-157
|
Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIRECT-TO-CONSUMER ADVERTIZING;
GEOGRAPHIC DISTRIBUTION;
HEALTH PROMOTION;
INTERNET;
MARKETING;
MEDICAL ETHICS;
NOTE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
STEM CELL;
TREATMENT INDICATION;
UNITED STATES;
CYTOLOGY;
DRUG INDUSTRY;
ECONOMICS;
ETHICS;
GEOGRAPHY;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
POLICY;
RISK;
DRUG INDUSTRY;
GEOGRAPHY;
HUMANS;
MARKETING;
POLICY;
RISK;
STEM CELLS;
UNITED STATES;
|
EID: 84978493321
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2016.06.007 Document Type: Note |
Times cited : (285)
|
References (10)
|